429 related articles for article (PubMed ID: 28150095)
1. Risk of ventricular tachyarrhythmias following improvement of left ventricular ejection fraction in patients with implantable cardiac defibrillators implanted for primary prevention of sudden cardiac death.
Pillarisetti J; Gopinathannair R; Haney MJ; Abazid B; Rawasia W; Reddy MY; Adabala N; Bommana S; Emert M; Lakkireddy D
J Interv Card Electrophysiol; 2017 Apr; 48(3):283-289. PubMed ID: 28150095
[TBL] [Abstract][Full Text] [Related]
2. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
3. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
Madhavan M; Waks JW; Friedman PA; Kramer DB; Buxton AE; Noseworthy PA; Mehta RA; Hodge DO; Higgins AY; Webster TL; Witt CM; Cha YM; Gersh BJ
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
[TBL] [Abstract][Full Text] [Related]
4. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register.
Weeke P; Johansen JB; Jørgensen OD; Nielsen JC; Møller M; Videbæk R; Højgaard MV; Riahi S; Jacobsen PK
Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630
[TBL] [Abstract][Full Text] [Related]
5. Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication.
Boersma LV; Barr CS; Burke MC; Leon AR; Theuns DA; Herre JM; Weiss R; Kremers MS; Neuzil P; Husby MP; Carter N; Stivland TM; Gold MR;
Heart Rhythm; 2017 Mar; 14(3):367-375. PubMed ID: 27890798
[TBL] [Abstract][Full Text] [Related]
6. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766
[TBL] [Abstract][Full Text] [Related]
7. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.
Kleemann T; Strauss M; Kouraki K; Zahn R
Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746
[TBL] [Abstract][Full Text] [Related]
8. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy.
Grimm W; Flores BT; Marchlinski FE
Circulation; 1993 Jun; 87(6):1880-8. PubMed ID: 8504500
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.
Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J
Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773
[TBL] [Abstract][Full Text] [Related]
10. Performance of the entirely subcutaneous ICD in borderline indications.
Willy K; Reinke F; Bögeholz N; Köbe J; Eckardt L; Frommeyer G
Clin Res Cardiol; 2020 Jun; 109(6):694-699. PubMed ID: 31586219
[TBL] [Abstract][Full Text] [Related]
11. Incidence of appropriate shock in implantable cardioverter-defibrillator patients with improved ejection fraction.
Naksuk N; Saab A; Li JM; Florea V; Akkaya M; Anand IS; Benditt DG; Adabag S
J Card Fail; 2013 Jun; 19(6):426-30. PubMed ID: 23743493
[TBL] [Abstract][Full Text] [Related]
12. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction.
Clementy N; Pierre B; Lallemand B; Marie O; Lemoine E; Cosnay P; Fauchier L; Babuty D
Europace; 2012 Jul; 14(7):968-74. PubMed ID: 22389416
[TBL] [Abstract][Full Text] [Related]
14. What is the optimal left ventricular ejection fraction cut-off for risk stratification for primary prevention of sudden cardiac death early after myocardial infarction?
Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
Europace; 2014 Sep; 16(9):1315-21. PubMed ID: 24599939
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
[TBL] [Abstract][Full Text] [Related]
17. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.
Gupta A; Harrington M; Albert CM; Bajaj NS; Hainer J; Morgan V; Bibbo CF; Bravo PE; Osborne MT; Dorbala S; Blankstein R; Taqueti VR; Bhatt DL; Stevenson WG; Di Carli MF
JACC Clin Electrophysiol; 2018 Sep; 4(9):1200-1210. PubMed ID: 30236394
[TBL] [Abstract][Full Text] [Related]
18. [Negative result of microvolt T-wave alternans test is helpful in scheduling the order of cardioverter-defibrillator implantation in primary prevention of sudden cardiac death in individuals with the left ventricular systolic dysfunction].
Daniłowicz-Szymanowicz L; Szwoch M; Raczak J; Raczak G
Pol Merkur Lekarski; 2012 Oct; 33(196):193-7. PubMed ID: 23272605
[TBL] [Abstract][Full Text] [Related]
19. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
[TBL] [Abstract][Full Text] [Related]
20. Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study.
Clementy N; Challal F; Marijon E; Boveda S; Defaye P; Leclercq C; Deharo JC; Sadoul N; Klug D; Piot O; Gras D; Bordachar P; Algalarrondo V; Fauchier L; Babuty D;
Heart Rhythm; 2017 Feb; 14(2):211-217. PubMed ID: 27989789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
